UBS lowered the firm’s price target on Xponential Fitness (XPOF) to $7 from $8 and keeps a Neutral rating on the shares, citing lower estimates.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XPOF:
- Xponential Fitness Launches Strategic Alternatives Review Amid Board Shift
- Xponential Fitness initiates review of strategic alternatives
- Kanen Wealth calls on Xponential Fitness to initiate strategic review
- Micron downgraded, Five Below upgraded: Wall Street’s top analyst calls
- Xponential downgraded to Market Perform from Strong Buy at Raymond James